MOH up +1.31% percent Today $MOH High is at 49.54 and the

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
MOH up +1.31% percent Today $MOH High is at 49.54 and the Low 48.59 with current volume of 101,084.

Recent News posted below.

Molina Healthcare Inc MOH other info.
http://investorshangout.com/Molina-Healthcare-Inc-MOH-51847/

MOH Molina Healthcare Inc Recent Headline News

Earnings Look Back: Molina Healthcare Is Up 4.8% Since Reporting Quarterly Results 2 Weeks Ago (MOH)
Comtex SmarTrend(R) - 2 hrs 14 mins ago
Two weeks ago on October 30th, 2014 Molina Healthcare (NYSE:MOH) reported earnings and analysts, on average, expected earnings of $0.42 on sales of $2.6 billion. The company actually reported EPS of $0.33 on sales of $2.5 billion, missing EPS estimates by $0.09 and missing revenue estimates by $119.5 million. Since the company's report, shares of Molina Healthcare have risen from $46.52 to $48.77, representing a gain of 4.8% in the past 18 days.
MOH: 49.39 (+0.62)

4 States Where Obamacare Premiums Are Falling
Sean Williams, The Motley Fool - Motley Fool - Fri Nov 14, 10:06AM CST
Source: White House on Flickr. Tomorrow is the big day. State and federally run health exchanges will open for business and consumers will get their first opportunity to really get a glimpse at the selection of health plans available to them. ...
UNH: 96.22 (+1.11), MOH: 49.39 (+0.62)

Molina Healthcare Hits 52-Week High on Strong Q3 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 11:20AM CST
On Nov 12, 2014, shares of Molina Healthcare, Inc. (MOH) reached a new 52-week high of $50.07.
WCG: 69.68 (+0.87), MOH: 49.39 (+0.62), MGLN: 61.40 (+0.52), HUM: 137.47 (+1.70)

Insider Trading Alert - CRZO, SEIC And MOH Traded By Insiders
at The Street - Mon Nov 10, 10:00AM CST
Stocks with insider trader activity include CRZO, SEIC and MOH
SEIC: 39.05 (-0.22), CRZO: 49.76 (-1.83), MOH: 49.39 (+0.62)

Insider Buys And Sells: Southern Copper Corp., Microsoft Corporation
Asif Suria - Seeking Alpha - Mon Nov 10, 9:04AM CST
Welcome to edition 229 of Insider Weekends. Insider buying increased last week with insiders buying $90.85 million of stock compared to $63.4 million in the week prior. Selling also increased significantly with insiders selling $2.18 billion of stock...
CCI: 80.05 (-0.34), SCCO: 30.15 (-0.38), STX: 63.38 (+0.51), SONS: 3.57 (-0.05), SIX: 40.40 (-0.07), NS: 59.21 (+0.41), MSFT: 49.52 (-0.06), MOH: 49.39 (+0.62), HUN: 25.66 (-0.08), OZRK: 35.89 (-0.23)

Molina Healthcare Earnings In Retrospect: Up 4.8% in the Last 11 Days (MOH)
Comtex SmarTrend(R) - Mon Nov 10, 8:48AM CST
11 days ago, on October 30th, 2014, Molina Healthcare (NYSE:MOH) reported its earnings. Analysts, on average, expected earnings of $0.42 per share on sales of $2.6 billion. Molina Healthcare actually reported earnings of $0.33 per share on sales of $2.5 billion, missing EPS estimates by $0.09 and missing revenue estimates by $119.5 million. Shares of Molina Healthcare have climbed from $46.52 to $48.75, representing a gain of 4.8% since the company reported earnings 11 days ago.
MOH: 49.39 (+0.62)

Molina Healthcare (MOH) Upgraded From Hold to Buy
at The Street - Mon Nov 10, 8:48AM CST
Molina Healthcare (MOH) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B.
MOH: 49.39 (+0.62)

These Companies Were Election Day Losers
Todd Campbell, The Motley Fool - Motley Fool - Sat Nov 08, 8:35AM CST
Source: Architect of the Capitol Flickr. The votes cast and counted, it appears that private Medicaid insurers including Centene , WellPoint , WellCare and UnitedHealth Group were among the losers. That's because those companies run...
CNC: 97.48 (+0.89), UNH: 96.22 (+1.11), WCG: 69.68 (+0.87), WLP: 126.66 (+1.30), MOH: 49.39 (+0.62)

5 Big Changes for Obamacare in 2015
Sean Williams, The Motley Fool - Motley Fool - Sat Nov 08, 8:26AM CST
Source: White House on Flickr. With mid-term elections now out of the way, consumers can begin turning their attention to two other important factors that roll around this time of year: the holiday season and Obamacare. Sure, buying gifts for...
UNH: 96.22 (+1.11), GIB: 36.55 (+0.34), ACN: 84.53 (-0.11), MOH: 49.39 (+0.62), RGC: 22.43 (+0.05)

DaVita Beats on Q3 Earnings, Down Y/Y; Updates Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 12:50PM CST
DaVita HealthCare Partners Inc. (DVA) reported third-quarter 2014 adjusted operating earnings of $1.01 per share that surpassed the Zacks Consensus Estimate of 91 cents.
DVA: 75.53 (-0.13), GTIV: 19.33 (unch), MOH: 49.39 (+0.62), WLP: 126.66 (+1.30)

Humana Posts Lackluster Q3 Earnings, Updates Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:54AM CST
Humana Inc.'s (HUM) third-quarter 2014 operating earnings came in at $1.85 per share, lower than the Zacks Consensus Estimate of $2.01.
AET: 85.82 (+2.01), MOH: 49.39 (+0.62), WLP: 126.66 (+1.30), HUM: 137.47 (+1.70)

Insider Trading Alert - ULTI, MOH And BRCM Traded By Insiders
at The Street - Thu Nov 06, 11:05AM CST
Stocks with insider trader activity include ULTI, MOH and BRCM
ULTI: 153.07 (-1.28), BRCM: 42.09 (-0.02), MOH: 49.39 (+0.62)

Gentiva Earnings Miss Estimates, Up Y/Y; Outlook Reiterated - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 9:00AM CST
Gentiva Health Services, Inc. (GTIV) reported third-quarter 2014 adjusted earnings of 28 cents per share, missing the Zacks Consensus Estimate by a penny.
KND: 19.40 (-0.52), GTIV: 19.33 (unch), MOH: 49.39 (+0.62), WLP: 126.66 (+1.30)

Health Net Q3 Earnings Miss By a Penny, Guidance Revised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 2:00PM CST
Health Net's (HNT) third-quarter 2014 operating income of 72 cents per share missed the Zacks Consensus Estimate by a penny and decreased 13% year over year due to higher expenses.
CTSH: 53.02 (-0.26), HNT: 50.95 (+1.15), MOH: 49.39 (+0.62), WLP: 126.66 (+1.30)

Tenet Healthcare Q3 Earnings Beat, Down Y/Y, Guides High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 12:30PM CST
Tenet Healthcare Corp. (THC) reported third-quarter 2014 operating earnings of 36 cents per share that surpassed the Zacks Consensus Estimate of 10 cents.
THC: 46.92 (+0.42), AET: 85.82 (+2.01), MOH: 49.39 (+0.62), WLP: 126.66 (+1.30)

Obamacare's Shocking Effect on Premium Prices
Sean Williams, The Motley Fool - Motley Fool - Sun Nov 02, 7:08AM CST
Source: White House on Flickr. The Affordable Care Act, which is best known in its shorthand form as Obamacare, was developed with a couple of goals in mind. One was obviously to reduce the number of uninsured people in the U.S. The idea here is...
CNC: 97.48 (+0.89), MOH: 49.39 (+0.62)

The 1 Factor That Could Send Obamacare Into a Death Spiral
Sean Williams, The Motley Fool - Motley Fool - Sat Nov 01, 7:38AM CDT
Source: White House on Flickr. Regardless of whether you're a proponent or opponent of the Affordable Care Act, better known as Obamacare, no one can deny that it's changed the healthcare landscape. For some lower-income citizens, it has provided...
CNC: 97.48 (+0.89), WLP: 126.66 (+1.30), MOH: 49.39 (+0.62)

Molina Healthcare ups earnings 113% in Q3
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 3:53PM CDT

MOH: 49.39 (+0.62)

Molina Healthcare (MOH) Marked As A Barbarian At The Gate
at The Street - Fri Oct 31, 9:54AM CDT
Trade-Ideas LLC identified Molina Healthcare (MOH) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
MOH: 49.39 (+0.62)

Molina Healthcare Beats on Q3 Earnings, Lowers Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 9:30AM CDT
Molina Healthcare Inc. (MOH) reported third-quarter 2014 operating earnings of 79 cents per share, handily beating the Zacks Consensus Estimate of 41 cents per share.
CI: 102.99 (+1.09), AET: 85.82 (+2.01), MOH: 49.39 (+0.62), WLP: 126.66 (+1.30)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 10

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Microbot Medical Secures $13 Million in Recent Offering

Updated Category News Views 92

Microbot Medical Makes Strategic Move with $13 Million Offering Microbot Medical Inc. (NASDAQ: MBOT) has recently taken an important step to elevate its operations by entering into definitive agreements to sell 6,103,289 shares of its common stock at a price of $2.13 per share. This registered direct offering, priced at-the-market under Nasdaq rules, underscores the...

Continue Reading
Evolv Technologies Faces Class Action Lawsuit: Know Your Rights

Updated Category News Views 651

Understanding the Evolv Technologies Holdings Class Action Recent developments have raised significant concerns among shareholders of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV). A class action lawsuit is currently in progress, prompting investors to scrutinize the implications of false statements made by the company. The allegations revolve around misleading...

Continue Reading
Rhino Rescue Unveils Innovative First Aid Kits for Adventurers

Updated Category News Views 117

Rhino Rescue Launches Innovative Products for Outdoor Safety Rhino Rescue has made a remarkable stride in enhancing outdoor safety with its new lineup of first aid kits targeted towards adventurers and everyday users alike. The release of the Rhino Rescue Mini First Aid Kit, along with home and camping-specific options, marks an exciting development in the company’s...

Continue Reading
RUSH's 2026 Tour: Celebrating Legacy and New Beginnings

Updated Category News Views 258

RUSH's 2026 Tour: A Celebration of Music and Legacy Geddy Lee and Alex Lifeson are set to celebrate over 50 years of RUSH's musical journey as they announce a special headline tour for 2026, named the Fifty Something Tour. This tour not only commemorates the incredible music and legacy of RUSH, but also pays tribute to their late drummer and lyricist Neil Peart, whose...

Continue Reading
BioSyent Inc. Announces Quarterly Dividend for Shareholders

Updated Category News Views 132

BioSyent Inc. Announces Quarterly Dividend for Shareholders MISSISSAUGA, Ontario — BioSyent Inc. (TSX Venture: RX) is thrilled to communicate that its Board of Directors has approved a quarterly dividend of $0.05 per common share. This dividend will be paid in Canadian Dollars on a specified date to shareholders who are on record, enhancing the company's ongoing...

Continue Reading